How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?

Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.

What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?

After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.

Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?

Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Strata Critical Medical, Inc. Class A Common Stock SRTA Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	——	-$27.31M+51.3%	-$56.08M-43.4%	-$39.11M-5.9%
Depreciation and amortization	$8.19M+37.3%	$5.96M-16.2%	$7.11M+24.2%	$5.73M+388%
Stock-based compensation	$17.83M-10.4%	$19.89M+59.1%	$12.5M+51.0%	$8.28M-26.6%
Deferred income taxes	——	——	-$1.6M-107%	-$772K—
Gain (loss) on sale of assets	——	$0+100%	-$48K—	——
Change in accounts receivable	$12.03M—	——	——	$5.35M+207%
Change in accounts payable	——	——	$9.05M—	——
Change in other assets	-$666K-1,051%	$70K—	——	——
Other working capital changes	——	$323K—	——	——
Change in deferred revenue	——	——	——	$737K—
Net cash from operating activities	-$48.91M—	——	-$34.37M+7.4%	-$37.13M-71.7%
Capital expenditures	$9.6M-68.9%	$30.86M+1,363%	$2.11M+189%	$730K+49.6%
Proceeds from maturities/sales of investments	——	$0—	——	$258.38M+806%
Purchases of intangible assets	$1.42M-33.2%	$2.12M—	$0—	$0—
Purchases of fixed maturity securities	$146.26M+2.1%	$143.26M—	——	$227.29M—
Net cash from investing activities	$69.75M—	——	——	——
Proceeds from issuance of common stock	$193K+14.9%	$168K+140%	$70K-19.5%	$87K-71.3%
Taxes paid for net share settlement	$9.11M+60.2%	$5.68M+3,792%	$146K-87.5%	$1.17M-63.1%
Payment of debt issuance costs	——	——	——	——
Net cash from financing activities	-$8.91M-54.7%	-$5.76M-7,478%	-$76K+93.0%	-$1.08M-100%
Effect of exchange rate changes on cash	-$339K-324%	-$80K—	——	$72K+900%
Net increase (decrease) in cash	——	-$9.37M+39.1%	-$15.4M—	——
Accretion (Amortization) of Discounts and Premiums, Investments	$2.21M-44.5%	$3.99M-38.8%	$6.52M+496%	$1.09M—
Change in fair value of other assets and liabilities	——	$0—	——	——
Gain on sale of business and assets	——	——	——	——
Increase (Decrease) in Operating Lease Assets And Liabilities	$90K+155%	-$164K—	——	-$611K-1,467%
Increase (Decrease) in Prepaid Expense and Other Assets	$1.69M—	——	——	$5.38M—
Payment of seller transaction costs	$44.34M—	$0—	——	——
Impairment of long-lived assets	$1.67M—	$0—	——	——
Payments to Acquire Held-to-Maturity Securities	$146.26M+2.1%	$143.26M—	——	$227.29M—
Payments to Acquire Intangible Assets	$1.42M-33.2%	$2.12M—	$0—	$0—
Transaction Costs Paid Related to Sale Of Business, Cash Transfer	——	——	——	——
Payments Of Debt Issuance Costs	——	——	——	——
Accrued payables for capital expenditures	——	——	$0—	——
Fair Value Adjustment Of Warrants	-$4.28M-603%	$850K—	——	-$24.23M-426%
Increase Decrease In Contract With Customer Liability	——	——	——	$737K—
New leases under ASC 842 entered into during the period	$1.6M-81.3%	$8.55M-12.4%	$9.76M+53.4%	$6.36M—
Modification of existing right-of-use assets ("ROU") and lease liability	$0-100%	$12.68M—	$0—	——
Free cash flow	-$58.51M-75.3%	-$33.38M+6.7%	-$35.79M+5.5%	-$37.86M-71.2%
Free cash flow	-$58.51M-75.3%	-$33.38M+6.7%	-$35.79M+5.5%	-$37.86M-71.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Strata Critical Medical, Inc. Class A Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?: Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.
What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?: After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.
Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?: Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.